Instrument Inactif

Autres langues Rain Oncology Inc.

Actions

RAIN

US75082Q1058

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Rain Oncology Acquisition by Pathos AI Completed	26/01
Pathos AI Completes Acquisition of Rain Oncology	26/01
Rain Oncology Inc.(NasdaqGS:RAIN) dropped from NASDAQ Composite Index	26/01
Rain Oncology Inc.(NasdaqGS:RAIN) dropped from S&P TMI Index	26/01
Pathos AI, Inc. completed the acquisition of Rain Oncology Inc. on January 26, 2024.	26/01
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN	05/01
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL	04/01
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN	18/12
Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos	14/12
Rain Oncology Agrees to be Acquired by Pathos AI	14/12
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders	14/12
Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights	14/12
Rain Oncology Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update	09/11
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences	16/10/23
Rain Oncology Insider Bought Shares Worth $279,030, According to a Recent SEC Filing	13/10/23
Concentra Biosciences, LLC submits a non-binding proposal to acquire Rain Oncology Inc. from Tang Capital Partners, LP, managed by Tang Capital Management, LLC and others for $45.5 million.	13/10/23
The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)	12/09/23
ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN	12/09/23
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)	11/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Rain Oncology Inc.

Actions

RAIN

US75082Q1058

Autres langues

Filtres